Efficacy News and Research

RSS
Caliber opens world's largest plant-made pharmaceutical facility in Bryan

Caliber opens world's largest plant-made pharmaceutical facility in Bryan

Multipolar electrocoagulation is a safe, effective therapy for Barrett's esophagus

Multipolar electrocoagulation is a safe, effective therapy for Barrett's esophagus

Tai chi exercise linked to improved quality of life in CHF patients

Tai chi exercise linked to improved quality of life in CHF patients

African-American couples with HIV can benefit from health promotion interventions

African-American couples with HIV can benefit from health promotion interventions

Men with high DHA levels may face risk of developing aggressive prostate cancer

Men with high DHA levels may face risk of developing aggressive prostate cancer

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

Red pepper consumption can help manage appetite

Red pepper consumption can help manage appetite

A.P. Pharma targets resubmission of APF530 NDA in 2012

A.P. Pharma targets resubmission of APF530 NDA in 2012

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

Curemark CM-182 demonstrates positive results for schizophrenia in transgenic chakragati model of psychosis

Curemark CM-182 demonstrates positive results for schizophrenia in transgenic chakragati model of psychosis

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

Creative approach can tackle bacterial infections in patients with cystic fibrosis

Creative approach can tackle bacterial infections in patients with cystic fibrosis

Anacor's AN2728 and GSK '052 new data to be presented at upcoming meetings

Anacor's AN2728 and GSK '052 new data to be presented at upcoming meetings

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Decision Resources: 63% of neurologists select Tysabri as effective MS treatment

Decision Resources: 63% of neurologists select Tysabri as effective MS treatment

Promedior to present PRM-151 study data in age-related macular degeneration at ARVO meeting

Promedior to present PRM-151 study data in age-related macular degeneration at ARVO meeting

Marinus initiates ganaxolone Phase 2 trial in posttraumatic stress disorder

Marinus initiates ganaxolone Phase 2 trial in posttraumatic stress disorder

Convergence initiates CNV2197944 Phase I study in chronic pain

Convergence initiates CNV2197944 Phase I study in chronic pain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.